(Q26866311)

Ulf P. Neumann

series ordinal

2

1 reference

Maximilian Schmeding

series ordinal

3

1 reference

language of work or name

1 reference

2015

1 reference

Gastroenterology research and practice

published in

1 reference

volume

2015

1 reference

page(s)

696120

1 reference

Creative Commons Attribution 3.0 Unported

copyright license

start time

1 January 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4302354

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4302354

Practical methods for incorporating summary time-to-event data into meta-analysis

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4302354

Percutaneous ablation therapy versus surgical resection in the treatment for early-stage hepatocellular carcinoma: a meta-analysis of 21,494 patients

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4302354

Radiofrequency ablation versus hepatic resection for the treatment of early-stage hepatocellular carcinoma meeting Milan criteria: a systematic review and meta-analysis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4302354

Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4302354

Role of surgical resection for multiple hepatocellular carcinomas

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4302354

Resection for hepatocellular carcinoma: is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4302354

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4302354

Resection and liver transplantation for hepatocellular carcinoma.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4302354

Aggregate data meta-analysis with time-to-event outcomes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4302354

Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas: a meta-analysis of randomized and nonrandomized controlled trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4302354

Staging systems in hepatocellular carcinoma

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4302354

Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness

31 May 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F696120

A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F696120

A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F696120

Liver resection improves the survival of patients with multiple hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F696120

Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F696120

Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F696120

Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F696120

Indications for hepatectomy for hepatocellular carcinoma - what stage of the disease is the best indication for surgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F696120

Nationwide study of 4741 patients with non-B non-C hepatocellular carcinoma with special reference to the therapeutic impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F696120

Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F696120

Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F696120

Locoregional therapy-induced tumor necrosis as a predictor of recurrence after liver transplant in patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F696120

Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F696120

Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F696120

Hepatic Resection Associated With Good Survival for Selected Patients With Intermediate and Advanced-Stage Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2015%2F696120

Liver transplantation for hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma

1 reference

12 December 2020

Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis: which is the best oncological approach?

1 reference

12 December 2020

Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus

1 reference

12 December 2020

Liver resection for HCC with cirrhosis: surgical perspectives out of EASL/AASLD guidelines

1 reference

12 December 2020

Identifiers

1 reference

1 reference

PubMed publication ID

25642245

1 reference